The wellness industry has a particular talent for taking things that are real and credible, surrounding them with so much exaggerated marketing that serious people stop taking them seriously, and then selling them at a markup to people who don’t know enough to be skeptical. Red light therapy is a case study in this phenomenon.
Stand in a red panel for a few minutes each day and you’ll find claims ranging from legitimate to delusional: collagen production, hair regrowth, fat loss, erectile dysfunction, longevity, brain health, “cellular rejuvenation.” The devices cost anywhere from $80 to several thousand dollars. Most of the influencers selling them have no idea why they’re supposed to work. Some of the devices don’t even emit the correct wavelengths.
And yet. The underlying science is real, the mechanisms are reasonably well understood, and a 2025 consensus panel of 21 clinical experts from across multiple medical disciplines just published their recommendations on which uses the evidence actually supports. The field has thousands of peer-reviewed studies, got an official designation from the National Library of Medicine in 2015, and has produced several FDA-cleared treatments. It’s not wellness theater, even if a lot of what surrounds it is.
The story of how this all started is worth knowing.
A lab accident in Budapest, 1967
Endre Mester was a physician and researcher at Semmelweis Medical University in Hungary. He’d read about an American experiment in which a high-powered ruby laser was used to successfully destroy tumors in rats, and he wanted to replicate it. What he didn’t realize was that his custom-built ruby laser was a tiny fraction of the power of the one used in the original experiment.
So he ran the study, shaved patches of fur off the mice, divided them into two groups, irradiated one group with his weak laser, and waited. No tumors died. But the mice exposed to the low-level laser light had noticeably faster hair regrowth and better wound healing than the control group. He called it “laser biostimulation” and spent the next several years investigating it systematically.
That’s the entire origin. An accidental underpowering of a laser, in Budapest, in 1967, leading to a medical field that now has thousands of clinical studies and FDA-cleared treatments.
The NASA chapter came two decades later. In the late 1980s, researchers were experimenting with red LEDs as a way to grow plants in space, where conventional grow lights were impractical because of their power consumption and heat. The plants responded well to the red light. The researchers also noticed something else: hand wounds they’d sustained during the work seemed to heal unusually fast. NASA followed up with a sponsored study in 2001 that exposed Navy SEALs to red light and documented significantly faster wound healing. LED photobiomodulation, as a consumer and clinical technology, follows directly from those experiments.
What’s actually happening inside the cell
The reason red light therapy works, to the extent that it works, is not mystical. There’s a specific molecular target, and the mechanism has been well characterized.
Inside virtually every cell in your body is a structure in the mitochondrial inner membrane called cytochrome c oxidase, or CCO. It’s the terminal enzyme in the electron transport chain — the final step in how your cells convert oxygen and nutrients into ATP, the molecule that powers almost everything a cell does. CCO contains copper and heme centers that have an unusual property: they absorb light in the red and near-infrared spectrum, roughly 600 to 900 nanometers.
When those photons hit CCO, something specific happens. Under conditions of cellular stress, inflammation, hypoxia, or damage, nitric oxide gets stuck to the enzyme and blocks oxygen from binding to it, throttling energy production. Red light photodissociates that inhibitory nitric oxide, freeing up the enzyme’s active site, increasing electron transport efficiency, and boosting ATP production. Secondary effects cascade from there: a brief and hormetic burst of reactive oxygen species that activates protective signaling pathways, a transient release of nitric oxide that improves local blood flow, and modulation of calcium levels that influences gene expression downstream.
This is why photobiomodulation shows its most dramatic effects in injured, inflamed, or metabolically stressed tissue. Healthy cells at baseline have relatively little inhibitory nitric oxide clogging their CCO. Cells that are damaged, hypoxic, or chronically inflamed have a lot. The therapy is essentially removing a brake that shouldn’t be there.
The relevant wavelength range is 600 to 1100 nanometers, which researchers call the “optical window” of biological tissue. Below 600 nanometers, hemoglobin absorbs the light before it gets very far. Above 1100 nanometers, water starts absorbing it. Red light in the 630–680 nanometer range penetrates roughly 5–10 millimeters, reaching skin layers and superficial tissue. Near-infrared light around 810–850 nanometers gets through 30–40 millimeters, reaching muscle and some internal tissue. That’s why the wavelength matters enormously for what you’re trying to treat, and why many consumer devices sold with vague or incorrect wavelength specifications are useless.
The biphasic problem
Here’s the thing that the $500 device marketing reliably leaves out: more red light is not better. In fact, above a certain dose, it’s actively worse.
This is called the biphasic dose response, or the Arndt-Schulz law, and it’s one of the most consistently replicated findings in the photobiomodulation literature. Low doses of light stimulate. Optimal doses produce maximum effect. High doses inhibit. In studies of cortical neurons irradiated with 810nm laser, ATP production peaked at around 3 joules per square centimeter. At 30 J/cm2, mitochondrial membrane potential actually dropped below baseline. The light that was supposed to energize the cell had suppressed it.
For practical purposes, the typical effective protocol is 3 to 10 minutes of exposure per area, at appropriate irradiance, with sessions spaced at least every 48–72 hours to allow the cells to respond. Sitting in front of a high-powered panel for 30 minutes daily because you figure more is better is not a good protocol. The research does not support it and may actually put you in the inhibitory range.
This is also why the dose is the thing, not the price tag. A cheap device that doesn’t put out enough energy does nothing. An expensive device used for too long or too close may do worse than nothing. The parameter that matters is joules per square centimeter delivered to the target tissue, and very few consumer device manufacturers make this easy to verify.
What the evidence actually supports
A 2025 consensus panel of 21 multidisciplinary experts, published in the Journal of the American Academy of Dermatology, went through the photobiomodulation literature and came to some clear conclusions. It’s worth knowing what they found.
The strongest evidence base belongs to oral mucositis. This is the painful mouth inflammation that develops as a side effect of chemotherapy and radiation treatment for cancer, and it’s genuinely awful. The Multinational Association of Supportive Care in Cancer issued clinical guidelines recommending photobiomodulation for it in 2019. The red and near-infrared light reliably reduces the severity and duration of mucositis in cancer patients, and this is one of the areas where the evidence has reached the highest level of rigor.
Hair loss, specifically androgenetic alopecia (male and female pattern loss), also has a solid evidence base. The FDA cleared low-level laser therapy devices for male pattern loss in 2007 and female pattern loss in 2011. Multiple double-blind, randomized controlled trials have shown improvements in hair density, thickness, and shaft diameter. One trial found low-level laser therapy performed comparably to minoxidil for hereditary hair loss, with the combination of both outperforming either alone. Worth noting: this works for follicles that are weakened or miniaturizing, not for follicles that are completely gone. If you’re bald, it’s not going to do much.
The 2025 consensus panel also confirmed evidence for treating several types of ulcers, peripheral neuropathy, and acute radiation dermatitis. The FDA has separately authorized the marketing of red light devices for dry age-related macular degeneration, and for fibromyalgia pain relief. None of this is fringe.
Skin rejuvenation has a reasonable but more modest evidence base. A 2014 randomized controlled trial involving 136 volunteers showed that red and near-infrared light produced improvements in skin complexion, texture, and intradermal collagen density over 12 weeks. The mechanism is vasodilation increasing nutrient delivery to skin tissue, plus direct effects on fibroblast activity and collagen gene expression. Stanford dermatologist David Ozog, who co-authored the 2025 consensus review, put it plainly: the skin effects are real, but modest. He’d rank red light below retin-A, vitamin C serums, or light laser peels for anti-aging results. That’s an important calibration for anyone dropping significant money on a home device with beauty claims.
What the evidence does not support
The claims that have run well ahead of the data: athletic performance enhancement, significant cognitive benefits in healthy people, longevity extension, erectile dysfunction, fat loss. These aren’t necessarily impossible; some have interesting preliminary animal or small human data. But “promising” is not the same as “supported,” and the wellness industry consistently treats them as equivalent.
Pankaaj Arany, a photobiomodulation researcher who has worked with several device companies, said it directly in a recent interview: just shining light on you is not going to make you superhuman in any way. The therapy’s effects are real where they’ve been rigorously tested. They’re probably much more modest than the general biohacking community tends to assume.
The other thing worth saying: if you’re hoping red light therapy compensates for poor sleep, a bad diet, or inadequate exercise, it doesn’t. It’s an adjunct. The mitochondrial benefits of red light are minor compared to what consistent aerobic exercise does to mitochondrial density and function.
The device problem
This is where it gets frustrating. The consumer market for red light therapy devices is genuinely messy.
FDA clearance means a device is considered safe. It does not mean it’s effective, and it says nothing about whether it actually delivers the therapeutic wavelengths at the therapeutic doses. Ozog, who has tested consumer devices extensively, has found some FDA-cleared products that simply don’t emit enough energy to have any biological effect. Others don’t emit the correct wavelengths to begin with, despite their marketing materials.
If you’re going to buy one, the most useful thing you can verify is independent third-party optical testing confirming the actual wavelengths emitted and the irradiance at a specified distance. Certifications from Intertek or UL confirm the device is electrically safe; they say nothing about whether it actually works. For skin rejuvenation, wavelengths in the 620–1072 nm range have evidence behind them, with longer wavelengths penetrating deeper. For hair loss, the well-studied range is 630–800 nm. For muscle recovery or deeper tissue effects, near-infrared around 810–850 nm is the target.
The free option is also worth knowing about: morning sunlight. When the sun is low on the horizon, its light travels through more atmosphere before reaching you, which scatters shorter (blue) wavelengths and lets more of the longer red and near-infrared wavelengths through. This is why early morning and evening light looks warm and red. You’re actually getting a favorable ratio of photobiomodulation-relevant wavelengths during those windows, for free, with zero risk of getting the dose wrong. It’s not going to replace a clinical-grade panel for treating active hair loss or wound healing, but for someone whose main interest is general cellular support and morning light exposure for circadian reasons, just going outside is a legitimate answer.
The honest version of the recommendation
Red light therapy is real. The mechanism is well-described, the evidence for specific applications is credible, and a serious multidisciplinary consensus exists that was just updated in 2025. For hair loss, oral mucositis prevention, wound healing, ulcers, peripheral neuropathy, and modest skin rejuvenation, the data is there. The FDA has cleared multiple devices and authorized devices for macular degeneration and fibromyalgia.
It’s not a miracle. The effects in healthy people doing it for general optimization are going to be subtler than the influencer content suggests. The device market is unreliable enough that buying the wrong product is a real possibility. And nothing about photobiomodulation changes the fundamental calculus of what determines your health — sleep, movement, food, stress.
But done correctly, 3 to 10 minutes a few times a week, with a device that actually emits the right wavelengths at the right dose, isn’t doing nothing. That’s more than most wellness habits can claim.
Sources:
- Hamblin, M.R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4(3), 337–361. PMC5523874.
- Hamblin, M.R. (2016). Photobiomodulation or low-level laser therapy. Journal of Biophotonics, 9(11–12), 1122–1124. PMC5215795.
- Touroutoglou, A. et al. (2020). Photobiomodulation and the proposed mechanisms. PMC5215870.
- Wunsch, A. & Matuschka, K. (2014). A controlled trial to determine the efficacy of red and near-infrared light treatment on skin roughness and intradermal collagen density. Photomedicine and Laser Surgery, 32(2), 93–100.
- Maghfour, J. et al. (2025). Evidence-based consensus on the clinical application of photobiomodulation. Journal of the American Academy of Dermatology, 93(2), 429–443.
- Herrera, M.A. et al. (2024). Red-light photons on skin cells and the mechanism of photobiomodulation. Frontiers in Photonics, 5, 1460722.
- Rahman, Z., Ozog, D., Arany, P. (2025). NPR/Stanford Medicine interviews on red light therapy evidence. Published April 2026.
- Mester, E., Szende, B., Gartner, P. (1968). The effect of laser beams on the growth of hair in mice. Radiobiology and Radiotherapy, 9, 621–626.
- PMC (2022). Role of low-level light therapy in androgenetic alopecia. PMC8906269.
- Frontiers in Ophthalmology (2024). Photobiomodulation translational research overview.
Leave a Reply